Publication | Closed Access
CUSHING'S SYNDROME IN PREGNANCY—TREATMENT WITH METYRAPONE
99
Citations
33
References
1982
Year
GynecologySevere CushingHigh-risk PregnancyReproductive EndocrinologyAdrenal GlandPublic HealthPlasma Cortisol 770Gestational DiabetesMaternal HealthPlasma CortisolMaternal-fetal MedicineAdrenal DiseaseEndocrinologyPlacental FunctionPhysiologyAdrenal HealthNeuroendocrine DisorderPregnancyMedicineEndocrine Disease
SUMMARY A 23‐year‐old female presented with severe Cushing's syndrome in the 23rd week of pregnancy. Investigations showed plasma cortisol 770 nmol/l (08.00 h) and 850 nmol/l (23.00 h); plasma ACTH was 10 ng/l (08.00 h) and 27 ng/l (23.00 h); urinary free cortisol excretion was 2460 nmol/24 h. Dexamethasone 2 mg 6‐hourly for 48 h suppressed the 08.00 h plasma cortisol only to 680 nmol/l. Abdominal C.T. scan showed a right adrenal adenoma. The patient was treated with metyrapone and a good clinical improvement ensued. Plasma cortisol was reduced to 300–500 nmol/l. Despite ultrasonographic evidence of normal fetal growth, urinary oestriol excretion was markedly deficient. Prior to the spontaneous onset of labour, there was a marked rise in plasma cortisol despite continuous metyrapone treatment. A normal female infant was born at 37 weeks' gestation. The maternal adrenal adenoma was subsequently removed. The deficiency of oestriol synthesis during the pregnancy may be explained by metyrapone‐induced inhibition of C19‐hydroxylation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1